Biophysical characterization and formulation of F1-V, a recombinant plague antigen.

J Pharm Sci

BD Technologies, 21 Davis Dr., Research Triangle Park, North Carolina 27519, USA.

Published: August 2009

AI Article Synopsis

  • The recombinant plague antigen F1-V exhibits a larger molecular weight than expected due to its disordered, worm-like conformation, indicated by various biophysical analyses.
  • Its solubility profile shows a minimum at pH 5, suggesting a tendency to aggregate when it lacks repulsive forces near its isoelectric point (pI).
  • When gradually renatured with specific conditions, F1-V stabilizes mainly in its monomeric form despite its innate propensity for aggregation as an unfolded protein.

Article Abstract

The recombinant plague antigen, F1-V, was studied for its structural characteristics using several biophysical techniques. A larger apparent molecular weight relative to its calculated molecular weight obtained from size exclusion chromatography, an unusually large R(g) obtained from MALS, and ANS dye binding studies which indicate that all hydrophobic regions of the protein are exposed to solvent demonstrated that F1-V exists like a disordered protein with a worm-like conformation. The pH-solubility profile of F1-V showed a solubility minimum at pH 5, close to its pI, consistent with the lack of repulsive forces that result in aggregation. Thus, in contrast to most globular proteins that exhibit a secondary and a tertiary structure, F1-V seems to lack tertiary structure and like an unfolded protein is more prone to aggregation via hydrophobic interactions. Despite this, when renatured gradually using descending guanidine hydrochloride concentration dialysis, in the presence of Mg+2, a surfactant and arginine hydrochloride at a pH of 7.5, F1-V appears to populate predominantly in its monomeric state.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jps.21652DOI Listing

Publication Analysis

Top Keywords

recombinant plague
8
plague antigen
8
molecular weight
8
tertiary structure
8
f1-v
6
biophysical characterization
4
characterization formulation
4
formulation f1-v
4
f1-v recombinant
4
antigen recombinant
4

Similar Publications

Article Synopsis
  • Hydrogen fuel production using photoelectrochemical (PEC) water-splitting offers a clean energy solution to address environmental challenges.
  • Introducing a ferroelectric layer (BTO) at the semiconductor/WOC interface enhances charge transfer and minimizes issues caused by electron-hole collisions.
  • The integration of ferroelectric BTO significantly improves charge separation and injection efficiency, potentially benefiting future electrocatalytic photoelectrode designs.
View Article and Find Full Text PDF

Critical blood shortages plague healthcare systems, particularly in lower-income and middle-income countries. This affects patients requiring regular transfusions and creates challenges during emergencies where universal blood is vital. To address these shortages and support blood banks during emergencies, this study reports a method for increasing the compatibility of blood group A red blood cells (RBCs) by blocking surface antigen-A using anti-A single chain fragment variable (scFv).

View Article and Find Full Text PDF

Delivery of antigens via outer membrane vesicles offered improved protection against plague.

mSphere

September 2024

State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China.

Outer membrane vesicles (OMVs) from Gram-negative bacteria can be used as a vaccine platform to deliver heterologous antigens. Here, the major protective antigens of F1 and LcrV, were fused either with the leader sequence or the transmembrane domain of the outer membrane protein A (OmpA), resulting in chimeric proteins OmpA-ls-F1V and OmpA-F1V, respectively. We show that OmpA-ls-F1V and OmpA-F1V can be successfully delivered into the lumen and membrane of the OMVs of respectively.

View Article and Find Full Text PDF

Background: Antibodies have been proven effective as diagnostic agents for detecting zoonotic diseases. The variable domain of camel heavy chain antibody (VHH), as an antibody derivative, may be used as an alternative for traditional antibodies in existing immunodiagnostic reagents for detecting rapidly spreading infectious diseases.

Objectives: To expedite the isolation of specific antibodies for diagnostic purposes, we constructed a semi-synthetic camel single domain antibody library based on the phage display technique platform (PDT) and verified the validity of this study.

View Article and Find Full Text PDF
Article Synopsis
  • Plague is caused by a bacterium and can show up as different types of disease; antibiotics are essential for treatment, but there's no FDA-approved vaccine yet, and some candidates may work better for certain forms of the disease.
  • The study tested new vaccine approaches on male and female mice and found that the best regimen involved an initial vaccination followed by a boost, with notable differences in effectiveness between sexes.
  • Results showed that female mice had better protection and immune responses compared to males, who also showed higher bacterial loads and different immune reactions, highlighting the importance of understanding sex differences in vaccine development.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!